Advanced in Multiple Sclerosis (MS)

Matthias G. Schwab

Tuebingen, BW, DE 
Advanced in Multiple Sclerosis (MS)
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Matthias Schwab practices in Tuebingen, Germany. Mr. Schwab is rated as an Advanced expert by MediFind in the treatment of Multiple Sclerosis (MS). His top areas of expertise are Dihydropyrimidine Dehydrogenase Deficiency, Thiopurine S-Methyltransferase Deficiency, Renal Cell Carcinoma (RCC), Colonoscopy, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 513 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Multiple Sclerosis (MS).

Gender
Male

Locations

Tuebingen, BW, Germany
Other Locations
Jena, TH, Germany
Heidelberg, BW, Germany
Dr Margarete Fischer Bosch Institute Of Clinical Pharmacology, Stuttgart, BW, Germany
Gelnhausen, HE 63571, Germany
Salem, BW, Germany
Eisenberg, TH 07607, Germany
Tubingen, Germany
Ludwigshafen Am Rhein, RP 67056, Germany
Mainz, RP 55128, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (TAMENDOX)
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (TAMENDOX)
Enrollment Status: Completed
Publish Date: September 17, 2021
Intervention Type: Drug
Study Drugs: (Z)-Endoxifen Supplementation According to Genotype, (Z)-Endoxifen Supplementation According to Plasma Levels
Study Phase: Phase 2

513 Total Publications

Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.
Journal: International journal of molecular sciences
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schwab's expertise for a condition
ConditionClose
    View All 79 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile